Abstract 2431: Enrichment of targetable mutations in the relapsed neuroblastoma genome

Neuroblastoma (NB) is a pediatric tumor responsible for 15% of pediatric cancer deaths. Patients with relapsed high-risk disease have less than a 5% chance of survival despite intensive cytotoxic chemotherapy regimens. Personalized therapies targeted against driver oncogenes may improve patient outc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.2431-2431
Hauptverfasser:	Padovan-Merhar, Olivia M., Raman, Pichai, Rubnitz, Kaitlyn R., Ali, Siraj M., Miller, Vincent A., Mosse, Yael P., Granger, Meaghan P., Weiss, Brian D., Maris, John M., Modak, Shakeel
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!